These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11600396)

  • 81. Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing.
    Pettit RK; Weber CA; Kean MJ; Hoffmann H; Pettit GR; Tan R; Franks KS; Horton ML
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2612-7. PubMed ID: 15980327
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The effect of nanoliposomal formulations on Staphylococcus epidermidis biofilm.
    Moghadas-Sharif N; Fazly Bazzaz BS; Khameneh B; Malaekeh-Nikouei B
    Drug Dev Ind Pharm; 2015 Mar; 41(3):445-50. PubMed ID: 24405445
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis.
    Rupp ME; Hamer KE
    J Antimicrob Chemother; 1998 Feb; 41(2):155-61. PubMed ID: 9533456
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of farnesol on planktonic and biofilm cells of Staphylococcus epidermidis.
    Gomes FI; Teixeira P; Azeredo J; Oliveira R
    Curr Microbiol; 2009 Aug; 59(2):118-22. PubMed ID: 19365686
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis model.
    Cavanagh JP; Granslo HN; Fredheim EA; Christophersen L; Jensen PØ; Thomsen K; Van Gennip M; Klingenberg C; Flaegstad T; Moser C
    J Antimicrob Chemother; 2013 Sep; 68(9):2106-10. PubMed ID: 23645587
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Concentration-Dependent Global Quantitative Proteome Response of
    Sung K; Park M; Chon J; Kweon O; Khan SA; Shen A; Paredes A
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359886
    [No Abstract]   [Full Text] [Related]  

  • 87. EDTA as a potential agent preventing formation of Staphylococcus epidermidis biofilm on polichloride vinyl biomaterials.
    Juda M; Paprota K; Jałoza D; Malm A; Rybojad P; Goździuk K
    Ann Agric Environ Med; 2008; 15(2):237-41. PubMed ID: 19118444
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Nitazoxanide inhibits biofilm formation by Staphylococcus epidermidis by blocking accumulation on surfaces.
    Tchouaffi-Nana F; Ballard TE; Cary CH; Macdonald TL; Sifri CD; Hoffman PS
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2767-74. PubMed ID: 20404119
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Sonodynamic action of hypocrellin B on biofilm-producing Staphylococcus epidermidis in planktonic condition.
    Wang X; Leung AW; Hua H; Xu C; Ip M
    J Acoust Soc Am; 2015 Oct; 138(4):2548-53. PubMed ID: 26520337
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics.
    Schwank S; Rajacic Z; Zimmerli W; Blaser J
    Antimicrob Agents Chemother; 1998 Apr; 42(4):895-8. PubMed ID: 9559803
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ultrasound Microbubbles Enhance the Activity of Vancomycin Against Staphylococcus epidermidis Biofilms In Vivo.
    Dong Y; Li J; Li P; Yu J
    J Ultrasound Med; 2018 Jun; 37(6):1379-1387. PubMed ID: 29159979
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Effect of sodium houttuyfonate in combination with erythromycin on luxS, agr/RNAⅢ of Staphylococus epidermidis].
    Xu GF; Wang JJ; Wu DQ; Guan Y
    Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(11):2131-2138. PubMed ID: 28822159
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inhibition of Staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives.
    Lawson MC; Hoth KC; Deforest CA; Bowman CN; Anseth KS
    Clin Orthop Relat Res; 2010 Aug; 468(8):2081-91. PubMed ID: 20191335
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Staphylococcus epidermidis biofilms: unexpected outcome of double and triple antibiotic combinations with rifampin.
    Gagnon RF; Richards GK; Wiesenfeld L
    ASAIO Trans; 1991; 37(3):M158-60. PubMed ID: 1751090
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparative rates of antibiotic action against Staphylococcus epidermidis biofilms.
    Richards GK; Gagnon RF; Prentis J
    ASAIO Trans; 1991; 37(3):M160-2. PubMed ID: 1751091
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo.
    Carmen JC; Roeder BL; Nelson JL; Beckstead BL; Runyan CM; Schaalje GB; Robison RA; Pitt WG
    J Biomater Appl; 2004 Apr; 18(4):237-45. PubMed ID: 15070512
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis.
    Monzón M; Oteiza C; Leiva J; Amorena B
    J Antimicrob Chemother; 2001 Dec; 48(6):793-801. PubMed ID: 11733463
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Differential Effects of Heated Perfusate on Morphology, Viability, and Dissemination of Staphylococcus epidermidis Biofilms.
    Beckwith JK; VanEpps JS; Solomon MJ
    Appl Environ Microbiol; 2020 Oct; 86(20):. PubMed ID: 32801173
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Vancomycin heteroresistance and biofilm formation in Staphylococcus epidermidis from food.
    Gazzola S; Cocconcelli PS
    Microbiology (Reading); 2008 Oct; 154(Pt 10):3224-3231. PubMed ID: 18832327
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The synergistic bactericidal effect of vancomycin on UTMD treated biofilm involves damage to bacterial cells and enhancement of metabolic activities.
    Hu J; Zhang N; Li L; Zhang N; Ma Y; Zhao C; Wu Q; Li Y; He N; Wang X
    Sci Rep; 2018 Jan; 8(1):192. PubMed ID: 29317687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.